Daniela P Ladner

Plain English
This study developed a new tool called the Liver Transplant Comorbidity Index (LTCI) to help identify liver transplant patients who are at a higher risk of dying within three years after their surgery. The research found that among 1,472 liver transplant recipients, 20% were frail, and those who were frail had a 13% chance of dying three years post-transplant, compared to 8% for non-frail patients. The LTCI takes into account five important factors, including frailty and other health conditions, making it easier for doctors to assess transplant risks and make better decisions for their patients. Who this helps: This helps doctors evaluate liver transplant candidates to ensure better outcomes for patients.

Plain English
This study focused on a new method called SPAP, which analyzes proteins found in human plasma, particularly those that are smaller and more complex. Researchers found that this method successfully identified 3,746 different protein forms from 255 proteins in a group of 40 individuals, including 30 patients with liver cirrhosis and 10 healthy people. This is important because it helps to accurately measure protein changes associated with liver disease and could lead to better diagnostic tools and treatments for various health conditions. Who this helps: This helps patients with liver disease and other conditions that require precise protein analysis.

Plain English
This study looked at how a recent policy change, which removed racial bias from kidney function calculations, affected Black patients waiting for kidney transplants. Out of 274 eligible Black patients, only 109 received reductions in their waiting time, gaining an average of 2.7 years, while many missed out due to unavailable lab results. This matters because it shows that while the new policy can help provide more fair access to transplants, many patients still face obstacles that prevent them from benefiting fully. Who this helps: This helps Black kidney transplant candidates.

Plain English
This study looked at how liver transplants affect survival rates for patients with different levels of frailty. Researchers found that although frail patients (28% before and 24% after transplant) are at a higher risk of dying while waiting for a transplant or after the procedure, they still benefit from getting a liver transplant. Specifically, receiving a liver transplant resulted in more years of life gained for all patients, regardless of their frailty level. Who this helps: This research helps patients with liver disease and their doctors in making informed decisions about transplant eligibility.

Plain English
This study looked at how often frail patients with cirrhosis end up in the hospital over a ten-year period. Out of nearly 37,000 patients, 44% were hospitalized, with those suffering from severe complications of cirrhosis facing a much higher rate of about 77 hospitalizations per 100 patients each year, compared to 14 hospitalizations for those with stable conditions. Understanding these hospitalization rates is important because it can help doctors identify at-risk patients and improve their treatment plans to potentially reduce hospital visits. Who this helps: This helps frail cirrhosis patients and their healthcare providers.

Plain English
This study looked at the costs of caring for patients with cirrhosis compared to those with heart failure and chronic obstructive pulmonary disease (COPD). Researchers found that the average monthly cost for cirrhosis care was $3,032, which is about 22% more than heart failure and 55% more than COPD. These findings show that cirrhosis care is very expensive and highlight the need to improve management to prevent the disease from getting worse. Who this helps: Patients with cirrhosis and their healthcare providers benefit from this information.

Plain English
This study looked at how cirrhosis, a serious liver disease, progresses and affects patient survival in the US. Researchers examined 12,196 patients and found that the risk of dying within one year increases significantly with the severity of the disease: for instance, those in the most severe stage (Stage 5) had a 43.8% chance of dying within a year, compared to just 7.3% for the least severe stage (Stage 1). Understanding these risks is crucial because it highlights the need for earlier referrals for liver transplants, as many patients are more likely to die than receive a transplant before the disease worsens. Who this helps: This benefits patients with cirrhosis and their doctors by emphasizing the importance of timely interventions and treatment decisions.

Plain English
This study looked at how effective a home-based exercise program could be for patients with liver disease awaiting a transplant. The program, which used exercise equipment, a smartphone app, and regular remote assessments, helped improve the frailty of these patients, as indicated by a decrease in their Liver Frailty Index score from 3.59 to 3.48 over about 259 days. In contrast, a similar group that did not participate in the exercise program showed no improvement, highlighting the program's potential benefits for patient health and survival. Who this helps: This helps patients with liver disease who are on the transplant waiting list.

Plain English
This study examined how sleep disturbances affected the ability of middle-aged and older adults with chronic conditions to manage their health during the COVID-19 pandemic. It found that 42.4% of participants experienced ongoing sleep problems, which were linked to factors like being under 60 years old, experiencing high stress, and having depression or anxiety. The research highlights that poor sleep can lead to difficulties in managing chronic health issues, suggesting that monitoring sleep quality could significantly improve health outcomes for these patients. Who this helps: Patients with chronic conditions.

Plain English
This study focused on creating a large collection of MRI scans to help better understand and analyze cirrhotic livers, which are severely damaged by chronic liver disease. Researchers gathered 628 high-quality MRI scans of cirrhotic livers and annotated nearly 40,000 individual images, allowing for more accurate analysis using advanced computer methods. This resource is important because it can improve the way doctors assess liver damage and tailor treatments for patients with cirrhosis. Who this helps: Patients with liver cirrhosis and their doctors.

Plain English
This study looked at the use of advanced artificial intelligence models in medical imaging, focusing on their benefits for detecting and diagnosing diseases. Researchers found that these AI systems can be incredibly effective, but also raise serious ethical issues, such as concerns about patient privacy and the potential for bias against certain groups. The study proposes a set of ethical guidelines to ensure these technologies are used responsibly, protecting patient information and promoting fairness in healthcare. Who this helps: Patients and doctors who rely on medical imaging for accurate diagnoses and fair treatment.

Plain English
This research introduces a new way to assess the impact of liver disease in patients with cirrhosis by using a method called the Disease Burden Score (DBS). The DBS measures how many health events, like heart problems or complications from liver disease, patients experience over time. The study found that this method gives accurate and reliable results, making it easier to track patient health and compare different groups of patients. Who this helps: This helps doctors and healthcare providers better understand and manage the health of patients with cirrhosis.

Plain English
This study developed a new computer system that uses advanced technology to automatically assess the severity of liver cirrhosis from MRI scans. The researchers tested their method on 628 MRI images from 339 patients and found it accurately classified cirrhosis stages in 72.8% of cases using one type of scan and 63.8% with another. This is significant because better early detection of cirrhosis can lead to timely treatment and improved patient outcomes. Who this helps: This helps patients with liver diseases by providing earlier and more accurate diagnoses.

Plain English
This study looked at liver transplants for people with alcohol-related liver disease, especially those who have not been sober for long. It found that patients who received transplants while still drinking had similar survival rates to those transplanted for other liver diseases, despite concerns about relapse and social issues. This is important because it suggests that earlier transplants could save lives, especially given the higher death rates when surgery is delayed. Who this helps: This helps patients with alcohol-related liver disease and their doctors.

Plain English
The Liver Cirrhosis Network launched a multicenter prospective study to track what happens to patients with early, compensated cirrhosis over time and identify who is at risk for serious complications. To support this, the network developed standardized definitions of cirrhosis and its complications — including ascites, bleeding, and liver cancer — to ensure consistent reporting across 10 clinical sites. These definitions and the cohort study design will produce more reliable data on the natural history of cirrhosis and help identify targets for preventing disease progression.

Plain English
This study looked at how well a short survey about physical ability (PROMIS) can identify frailty and predict hospitalizations in patients being evaluated for liver transplants. Researchers found that among 81 patients, 15% were considered frail, and they were hospitalized an average of 1.1 days each month. The findings indicate that using this quick survey can help estimate which patients may need more medical attention, making it easier for doctors to manage care. Who this helps: This helps patients waiting for liver transplants and their healthcare providers.

Plain English
This research paper focuses on how to better support surgeon-scientists, who are doctors that also conduct medical research. The study found that these professionals face significant challenges, like limited institutional support, high clinical workloads, and administrative burdens. The task force created specific recommendations for improving conditions, including better mentorship, financial support, and strategic hiring practices. Addressing these issues is important because enhancing the work environment for surgeon-scientists can lead to more breakthroughs in medicine. Who this helps: This benefits patients, doctors, and the broader medical community.

Plain English
This study looked at how body weight affects the recovery of patients after a liver transplant. Researchers found that patients with higher obesity levels (BMI of 35 or more) had more complications, such as a 106% greater chance of developing venous thrombosis and a 145% greater chance of wound dehiscence compared to non-obese patients. While survival rates were similar regardless of weight, those with obesity stayed in the hospital longer. Who this helps: This information benefits patients undergoing liver transplants and their healthcare providers by highlighting the need for careful monitoring of complications related to obesity.

Plain English
This study looked at how frailty, measured by the Liver Frailty Index (LFI), affects hospital stays for older adults after liver transplantation. Researchers found that older patients who were considered frail were hospitalized an average of 5 days longer than those who were not frail, and even a small increase in the LFI was linked to longer hospital stays. This matters because identifying frail patients could help healthcare providers plan better pre- and post-transplant care to reduce hospital time and improve recovery. Who this helps: This helps patients, particularly older adults undergoing liver transplantation, and their doctors.

Plain English
This study looked at how living in poorer neighborhoods affects people with liver disease (cirrhosis) in Chicago. Researchers found that as neighborhood deprivation increases, patients faced worse health outcomes: for every step up in deprivation, the risk of complications upscaled by 7%, the chances of being placed on a liver transplant list decreased by 28%, and the risk of dying increased by 9%. This matters because it highlights that where someone lives can significantly impact their health and access to life-saving treatments. Who this helps: This helps patients with liver disease, especially those in low-income areas.

Plain English
This study looked at the number of adults in the U.S. who have liver cirrhosis, a serious condition that often goes unnoticed, from 2012 to 2018. Researchers found that the prevalence of cirrhosis more than doubled, rising from 0.34% in 2012 to 0.71% in 2018, with particular increases seen in cases related to alcohol and a condition called NASH. This matters because it highlights a growing health crisis that could overwhelm the healthcare system, especially in Southern states where the rates soared the fastest. Who this helps: This helps patients with liver conditions and healthcare providers.

Plain English
This study looked at a new MRI method to measure muscle health in patients with severe liver disease. Out of 18 patients, 41% showed poor muscle quality, which was linked to them needing a specific procedure for fluid removal and led to worse performance on a walking test (an average of 379 meters compared to 470 meters for others). This is important because understanding muscle health can help improve care for those with end-stage liver disease. Who this helps: Patients with end-stage liver disease and their healthcare providers.

Plain English
This study looked at how changes in the Liver Frailty Index (LFI) could predict survival for patients with cirrhosis waiting for a liver transplant. Researchers found that even a small improvement of 0.1 in the LFI decreased the risk of dying while on the waiting list by 6%. This is important because it suggests that making small improvements in physical strength can significantly help patients stay alive longer while waiting for a transplant. Who this helps: This helps patients with cirrhosis, their families, and healthcare providers working with them.

Plain English
This study looked at how proteins in the blood can indicate the progression of liver cirrhosis, a serious liver disease affecting millions of Americans. Researchers found 209 different proteins that change in levels across three stages of cirrhosis, helping to identify which patients are at higher risk of worsening health. This is important because it can guide doctors in providing the right care to those who need it most, potentially improving survival for patients with liver cirrhosis. Who this helps: This benefits patients with liver cirrhosis and their doctors.

Plain English
This study examined different ways to predict survival rates in patients with liver cirrhosis using electronic health records. The researchers compared several advanced modeling techniques that take into account changes over time, and found that these dynamic models provide better predictions than traditional methods. For instance, using these newer models can help accurately forecast who is at risk for worsening health, which is crucial for timely treatment decisions. Who this helps: This helps doctors and patients with liver cirrhosis by providing better predictions for survival.

Plain English
This study looked at how well a simple questionnaire about cognitive function can identify people with cirrhosis who might experience confusion, a condition called hepatic encephalopathy (HE). Researchers found that patients who reported poorer cognitive abilities on the questionnaire had a significantly higher chance of being hospitalized: the rate of hospital admissions was about 1.6 days per month, and the survey could predict future hospital stays. This is important because it offers an easy way for doctors to identify at-risk patients and potentially prevent hospitalizations. Who this helps: This helps patients with cirrhosis and their doctors by providing a quick method to spot cognitive issues that could lead to hospital stays.

Plain English
This study looked at two ways to assess patients' health before they receive a liver transplant: looking at muscle mass (sarcopenia) and overall frailty. Among 426 transplant patients, 31% were found to be sarcopenic, and 25% were identified as frail. Patients with lower muscle mass and higher frailty scores ended up staying longer in the hospital after their surgeries—sarcopenic patients averaged 14 days compared to 11 for those without muscle issues. Overall, while neither measure directly predicted survival one year after surgery, frailty scores were notably linked to higher mortality rates. Who this helps: This information helps doctors better evaluate and care for patients awaiting liver transplants.

Plain English
This study looked at how transplant recipients with weakened immune systems respond to the virus that causes COVID-19 compared to people with normal immune systems. Researchers found that the antibodies produced by transplant recipients are similar in strength and composition to those in healthy individuals, and that the changes in these antibodies over time were also alike. This is important because it shows that even though transplant patients have compromised immune systems, their bodies can still produce an effective antibody response to COVID-19. Who this helps: This helps transplant patients and their doctors understand how their immune systems respond to COVID-19.

Plain English
This research reviewed how social factors, like money, education, and community support, affect patients with chronic liver disease (CLD). The study found that patients facing economic difficulties, lack of healthcare access, and poor living conditions had higher rates of death and hospital readmissions. Specifically, those living more than 25 miles from a liver transplant center were more likely to die, even with access to waiting lists. Who this helps: This information helps patients with chronic liver disease, healthcare providers, and policymakers.

Plain English
The study focused on the challenges that Black Americans face when trying to access kidney transplants, highlighting that they experience end-stage kidney disease at a higher rate than other groups. It introduced the African American Transplant Access Program (AATAP), designed to improve access by addressing cultural and systemic barriers. Early results show that this program effectively meets the needs of Black patients, helping to ensure they receive the vital transplants they need. Who this helps: This benefits Black patients with kidney disease seeking transplants.

Plain English
This study looked at how proteins in the blood can indicate the progression of liver cirrhosis, a serious liver disease affecting millions of Americans. Researchers found 209 different protein forms in patients with various stages of cirrhosis, which may help identify those at high risk of serious complications. This is important because knowing which patients are more likely to face deterioration can help doctors provide timely and specialized care, improving survival rates. Who this helps: Patients with liver cirrhosis and their healthcare providers.

Plain English
This study developed a new computer program called PAM-UNet that improves how medical images, like those used for detecting liver tumors, are analyzed. The researchers found that this new approach achieved a high accuracy score, with a mean Intersection over Union (IoU) of 74.65 and a dice score of 82.87, while being 10 times faster than similar methods. This matters because better and quicker image analysis can help doctors make more accurate diagnoses and treatment decisions. Who this helps: Patients and doctors involved in diagnosing and treating liver tumors.

Plain English
This study looked at how frailty affects the quality of life for people who have received a liver transplant. Researchers found that out of 358 liver transplant recipients, 19% were considered frail before their surgery. A year after the transplant, frail recipients reported a significantly lower score in physical health quality (42 points) compared to non-frail recipients (50 points), indicating that frailty leads to worse physical health outcomes after the transplant. Who this helps: This information benefits liver transplant patients and their doctors by highlighting the importance of managing frailty to improve recovery and overall health.

Plain English
This study looked at how multidrug-resistant germs affect critically ill patients with liver disease (cirrhosis) in intensive care units. Out of 600 admitted patients, 58% developed infections, with 33% carrying these resistant germs. The results showed that patients with these infections or germs had a much lower chance of surviving without a liver transplant, indicating that these resistant germs can significantly worsen patient outcomes. Who this helps: This research benefits doctors and healthcare providers managing critically ill cirrhosis patients.

Plain English
This study examined how sleep disturbances affected middle-aged and older adults with chronic health issues during the COVID-19 pandemic. Researchers found that about 42% of the 549 participants experienced ongoing sleep problems, which were linked to factors like older age, ongoing stress, and mental health issues such as anxiety and depression. Poor sleep not only worsened their mental and physical health but also made it harder for them to manage their chronic conditions effectively. Who this helps: This research helps patients with chronic conditions and their healthcare providers.

Plain English
This study looked at how end-stage liver disease (ESLD) affects the likelihood of developing heart failure (HF). Researchers analyzed health records from over 5,000 patients and found that those with ESLD were nearly five times more likely to develop heart failure than those without it. Specifically, 121 new cases of heart failure were identified during the follow-up period, and most of these cases in ESLD patients involved heart failure with preserved ejection fraction, which means the heart pumps normally but has other problems. Who this helps: This research is beneficial for patients with end-stage liver disease and their healthcare providers.

Plain English
This research looked at how many liver transplant patients, who had liver damage from cirrhosis, experience problems with thinking and memory after their surgery. Out of 847 patients studied, the rate of cognitive impairment ranged from 0% to 36%, with attention and executive function being the most affected areas. These findings are important because they highlight that cognitive issues can continue even after a liver transplant, which can impact a patient's quality of life. Who this helps: This helps patients recovering from liver transplants and their doctors.

Plain English
This study looked at how the COVID-19 pandemic affected the well-being and health management of adults with chronic conditions. Researchers found that about 20% of participants felt constant stress from the pandemic, 22% engaged in dangerous drinking habits, and nearly 80% did not exercise enough. Many also avoided medical care due to fears about COVID-19, which made it harder for them to manage their health. Who this helps: This information is important for patients with chronic conditions and their healthcare providers to improve support and care during similar crises.

Plain English
This study looked at how technology can help liver transplant patients stick to their medication routines, which is important for their recovery. Researchers tested a program that sends text message reminders to patients to encourage them to take their medications properly, comparing it to standard care. They found that better medication adherence could lead to fewer hospitalizations and improved patient quality of life. Who this helps: This benefits liver transplant patients by improving their medication adherence and overall health outcomes.

Plain English
This study looked at how doctors choose patients for receiving lower-quality kidneys, which are often discarded despite having the potential to help patients on the transplant waiting list. It found that doctors were less likely to accept these kidneys if their quality was poor or if important information about them was missing. They preferred patients who were younger, had waited less time for a transplant, and did not have diabetes, which shows that doctors often prioritize patients who are more likely to do well after surgery. Who this helps: This benefits patients waiting for kidney transplants, especially those in need of better access to available kidneys.

Plain English
Researchers studied the personality traits of 263 patients with cirrhosis who were being evaluated for liver transplants. They found that these patients were generally more open, extroverted, agreeable, and neurotic than the average person, but less conscientious. Importantly, those with higher conscientiousness were nearly three times more likely to receive a liver transplant, highlighting that personality can significantly affect treatment outcomes in liver disease.

Plain English
This study looked at the health of organ donors in the U.S. from 2005 to 2019 to see how it affects the number of organs available for transplants. It found that while donors are getting younger and have higher rates of obesity, diabetes, and other health issues, more of them are still being used for transplants—93.9% of potential donors were used. This matters because it highlights that even donors with serious health problems are being considered, which could help address the ongoing shortage of organs for people needing transplants.

Plain English
Living donor liver transplantation can reduce deaths on the waitlist, but its use in the U.S. remains low. This consensus conference report from the American Society of Transplantation identified barriers to wider adoption and outlined best practices for selecting candidates and engaging potential donors. The goal is to increase access to living donor transplants across more transplant centers.

Plain English
This study looked at a program called TAKE IT, designed to help kidney transplant patients stick to their medication routines. Over three months, 81% of participants completed at least one adherence assessment, and 50% reported problems adhering to their medication, with common issues being complexity of the regimen or forgetting to take meds. This matters because better adherence can lead to improved health outcomes for transplant recipients. Who this helps: Patients who have received kidney transplants.

Plain English
This study looked at how common sleep problems are among adults in the U.S. with ongoing health issues during the COVID-19 pandemic. It found that 20% of the 715 participants reported poor sleep, with Black adults being twice as likely to experience sleep disturbances compared to White adults. Factors like physical health issues, stress, depression, and anxiety were linked to poor sleep, while being vaccinated and being older than 70 seemed to help protect against it. Who this helps: This helps patients with chronic conditions, especially those experiencing sleep difficulties.